The Patent Finder

Comet Therapeutics, Inc.

Also on record
Records under this name other than patents Comet Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Comet Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 10,624,908Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,037,354Cyclic Pantetheine Derivatives and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,963,472Stable pantetheine derivatives for the treatment of pantothenate kinase associated neurodegeneration (PKAN) and methods for the synthesis of such compounds
Formerly held
Lapsed on the fee record
Ended May 8, 2026 · From the USPTO record
Lapsed on the fee recordEnded May 8, 2026From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited